Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)

The summary for the Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional): This Notice of Funding Opportunity (NOFO) seeks to stimulate HIV/AIDS research within the mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) that align with the HIV/AIDS research priorities outlined by the NIH Office of AIDS Research (OAR). These priorities were most recently described in NOT-OD-20-018 UPDATE: NIH HIV/AIDS Research Priorities and Guidelines for Determining HIV/AIDS Funding.

Federal Grant Title:	Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)
Federal Agency Name:	National Institutes of Health (HHS-NIH11)
Grant Categories:	Food and Nutrition, Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PAS-25-073
Type of Funding:	Grant
CFDA Numbers:	93.847
CFDA Descriptions:	Information not provided
Current Application Deadline:	January 7th, 2028
Original Application Deadline:	January 7th, 2028
Posted Date:	January 8th, 2025
Creation Date:	January 8th, 2025
Archive Date:	February 12th, 2028
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No
Last Updated:	January 8th, 2025

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement: https://grants.nih.gov/grants/guide/pa-files/PAS-25-073.html
Grant Announcement Contact: NIH Grants Information
[email protected]
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Similar Government Grants: • Single Source for Continuation of the Accelerating Medicines Partnership (AMP) in Common M...; • Single Source Renewal for the Continuation of the Liver Cirrhosis Network: Scientific and ...; • Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Train...; • Diabetes Research Centers (P30 Clinical Trial Optional); • Limited Competition Renewal for the Continuation of the Liver Cirrhosis Network: Clinical ...; • Proteomic and Metabolomic Approaches to Diagnose Diabetes and Pre-Diabetes; • Molecular Therapy Core Centers; • Pilot and Feasibility Program in Human Islet Biology
More Grants from the National Institutes of Health: • Single Source for Continuation of the Accelerating Medicines Partnership (AMP) in Common M...; • The NINDS Human Biospecimen and Data Repository (U24 - Clinical Trial Not Allowed); • National Centers for Cryo-electron Tomography (cryoET) (R24 -Clinical Trial Not Allowed); • Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clin...; • The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not...